Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial (Q43027727)

From Wikidata
Jump to navigation Jump to search
scientific article published on 9 June 2010
edit
Language Label Description Also known as
English
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial
scientific article published on 9 June 2010

    Statements

    Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial (English)
    Mads Ravnborg
    Magnus Andersson
    Peter J Jongen
    Irina Elovaara
    Emmanuel Bartholomé
    Karsten Beer
    Bjørn Sperling
    9 June 2010
    672-680

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit